Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
05/12/2010 | CN1879743B Oral liquid of litchi seed and method for making same |
05/12/2010 | CN1879724B A method for preparing blood fat-reducing natural product |
05/12/2010 | CN1879683B An health food capable of lowering blood pressure and blood sugar and preparation method thereof |
05/12/2010 | CN1853637B Use of pentacyclic triterpene compound as glycogen phosphorylase inhibitor |
05/12/2010 | CN1839812B Glibenclamide solid dispersion agent , oral single-ingredient or compound formulation and its preparation method |
05/12/2010 | CN1835762B Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
05/12/2010 | CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists |
05/12/2010 | CN1736977B crystallized (+)-(1S,2S,3S,4R,5R)-1-amido-5-hydroxymethyl-N-2(1,3-dihydroxypropyl)-2,3,4-cyclohexanetriol and its preparation method |
05/12/2010 | CN1694960B Use of saccharomyces cerevisiae ERG4 mutants for expressing mammalian glucose transporters |
05/12/2010 | CN1680544B Acid and choline-resistant separated strain of lactobacillus with ability of reducing and assimilating cholesterol |
05/12/2010 | CN1671856B Novel physiologically active substances |
05/12/2010 | CN1617715B Treating muscle wasting with selective androgen receptor modulators |
05/12/2010 | CN1565467B Use of cornel and its extract in preparation alpha-glucosidase inhibitor medicine |
05/12/2010 | CN1537000B Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
05/12/2010 | CN1466451B Ion-strength independent sustained release pharmacetuical formulation |
05/12/2010 | CN1366991B Application of plant extract for preparing medicine to cure bone absorption increment diseases, and compositon thereof |
05/12/2010 | CN101707910A Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity |
05/12/2010 | CN101704874A Pentacyclic triterpene and melbine salt of derivative thereof, preparation method and medical application of pentacyclic triterpene |
05/12/2010 | CN101704797A compounds effecting glucokinase |
05/12/2010 | CN101703761A Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
05/12/2010 | CN101703759A Lecithin high-calcium capsules and production process thereof |
05/12/2010 | CN101703702A Method for making lipid-lowering diet tea |
05/12/2010 | CN101703686A Chinese medicinal composition for treating diabetes |
05/12/2010 | CN101703684A Medicament for treating allergic purpura and preparation method thereof |
05/12/2010 | CN101703670A Three-high danshu capsule and production and preparation process thereof |
05/12/2010 | CN101703651A Medicament for treating diabetic gangrene |
05/12/2010 | CN101703643A Chinese medicinal preparation with effect of reducing blood sugar |
05/12/2010 | CN101703641A Chinese Medicinal composition for losing weight |
05/12/2010 | CN101703637A Compound lipidol-reducing extract preparation granule and production technique thereof |
05/12/2010 | CN101703617A Medicinal composition for treating diabetic nephropathy and preparation method thereof |
05/12/2010 | CN101703579A Chinese medicinal composition for treating diabetes |
05/12/2010 | CN101703577A Preparation method of guava leaf extract and traditional Chinese medicine preparation thereof |
05/12/2010 | CN101703566A Application of shishen in preparing medicine for treating II type diabetes |
05/12/2010 | CN101703546A Sanchi extract pellets and preparation method thereof |
05/12/2010 | CN101703545A Ginkgo American ginseng saponin capsule and preparation method thereof |
05/12/2010 | CN101703544A Pellet of acanthopanax senticosus extract and preparation method thereof |
05/12/2010 | CN101703534A Natural ginkgo extract capsule and preparation method thereof |
05/12/2010 | CN101703533A Ginkgo ganoderma lucidum spore capsule and preparation method thereof |
05/12/2010 | CN101703532A Ganoderan polysaccharide pellet and preparation method thereof |
05/12/2010 | CN101703528A Compound microbial preparation for treating diabetes, preparation method thereof and application thereof |
05/12/2010 | CN101703522A Medicinal and edible product for calcium supplement and preparation method thereof |
05/12/2010 | CN101703479A Resveratrol pellet and preparation method thereof |
05/12/2010 | CN101703478A Zinc gluconate pellets and preparation method thereof |
05/12/2010 | CN101703475A Chondroitin sulfate pellet and preparation method thereof |
05/12/2010 | CN101366884B Preparation technique for compound formulation for reducing blood fat and blood sugar |
05/12/2010 | CN101220100B Separation and purification method for squash polyoses and use of obtained component |
05/12/2010 | CN101204465B Rehmanniae thirstiness-dispelling tea |
05/12/2010 | CN101190179B Enteric medicinal composition for treating diabetes and preparation method thereof |
05/12/2010 | CN101139558B Lactobacillus acidophilus and its application for improvement of blood lipid metabolism and immunological regulation |
05/12/2010 | CN101139557B Lactobacillus casei and its application for improvement of blood lipid metabolism and immunological regulation |
05/12/2010 | CN101130771B Nucleotide molecule SR3B2 and application of the same in producing antidiabetic medicament |
05/12/2010 | CN101130768B Nucleotide molecule SR1B and application of the same in producing antidiabetic medicament |
05/12/2010 | CN101130090B Application of BRSK2 in producing antidiabetic medicine |
05/12/2010 | CN101113146B Process for the separation of blood fat recovery purpose-made monascus active ingredient |
05/12/2010 | CN101108207B Antidiabetic pharmaceutical composition and method of preparing the same |
05/12/2010 | CN101108175B Acid-alkaline buffering composition |
05/12/2010 | CN101104012B Medicine for treating cardiovascular disease |
05/12/2010 | CN101062086B Composite medicine for reducing blood fat and dissolving thrombus and its preparing process |
05/12/2010 | CN101049356B Pharmaceutical composition of containing puerarin and leaves of hawthorn |
05/12/2010 | CN101045076B Extractive of persimmon leaves ethyl acetate used for prevention and/or treatment of glycolipid metabolism related diseases |
05/12/2010 | CN101040645B Lotus tea having health-care and weight-losing effect |
05/12/2010 | CN101019641B Process of producing black food containing plant melanin |
05/12/2010 | CN101015627B Medicine composition for treating diabetes and its preparation |
05/12/2010 | CN101015379B Process for preparing agaricus blazei healht-care liquid |
05/12/2010 | CN101011561B Modern traditional Chinese medicine oral preparation huanglianwendan decoction and production method thereof |
05/12/2010 | CN101011421B Pollen tablet and its preparing process |
05/12/2010 | CN101007064B Isolation and purification method of lotus leaf extract by macroporous resin and its application thereof |
05/11/2010 | US7714170 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis |
05/11/2010 | US7714108 Mammalian tumor susceptibility gene products and their uses |
05/11/2010 | US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
05/11/2010 | US7714003 Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides |
05/11/2010 | US7713984 Pharmaceutical uses |
05/11/2010 | US7713982 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione: hyperlipoproteinaemia, dyslipidaemia, heart failure, hypercholesteraemia, atherosclerosis, arteriosclerosis, and hypertriglyceridaemia |
05/11/2010 | US7713971 Antidiabetic agents; dyslipidemia; hhypoglycemic agents; atherosclerosis ; obesity; antiinflammatory agents; metabolism disorders |
05/11/2010 | US7713963 Acylated indanyl amines and their use as pharmaceuticals |
05/11/2010 | US7713930 Acidic insulin preparations having improved stability |
05/11/2010 | US7713554 Use of enhanced water to improve blood sugar management |
05/11/2010 | CA2536544C 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
05/11/2010 | CA2456095C An improved process for the preparation of amorphous atorvastatin calcium salt (2:1) |
05/11/2010 | CA2434670C Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
05/11/2010 | CA2422299C Triazole compounds useful as protein kinase inhibitors |
05/11/2010 | CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
05/11/2010 | CA2410177C Thrombin receptor antagonists |
05/11/2010 | CA2318696C Triazepinones, process for their preparation and their therapeutic application |
05/07/2010 | CA2684853A1 Dietary supplement for promoting wellness and weight loss and methods of administering the same |
05/06/2010 | WO2010050793A1 Uses of curculigo latifolia (c. latifolia) extracts |
05/06/2010 | WO2010050525A1 Compound having tafia inhibitory activity |
05/06/2010 | WO2010050508A1 Peptide having anti-diabetic activity and use thereof |
05/06/2010 | WO2010050456A1 Piperidine compound having di- or tri-arylmethyl structure |
05/06/2010 | WO2010050445A1 Bicyclic compound |
05/06/2010 | WO2010050422A1 Agent for treatment of diabetes |
05/06/2010 | WO2010050191A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same |
05/06/2010 | WO2010050179A1 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient |
05/06/2010 | WO2010050168A1 Solid solution of valine, isoleucine and leucine, and method for producing same |
05/06/2010 | WO2010049900A1 Statin nanoparticles |
05/06/2010 | WO2010049798A1 A method of characterizing phytochemicals from trigonella foenum graceum |
05/06/2010 | WO2010049678A2 Treatment of energy utilization diseases |
05/06/2010 | WO2010049635A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1 |
05/06/2010 | WO2010049590A2 A new pharmaceutical product |
05/06/2010 | WO2010048955A1 Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition |